The Sam and Ann Barshop Institute for Longevity and Aging Studies at 51²è¹Ý is one of the world’s premier institutes dedicated to age-related diseases and is the only aging-intensive research institute in the country to have four designations. Barshop Institute’s mission in understanding the basic biology of aging and discovering therapies that will treat and cure debilitating aging diseases. 
The Barshop Institute supports its predoctoral and postdoctoral trainees in part through the Biology of Aging Training Program (T32). This program allows them to design, conduct and present their research to those focused on aging research.
51²è¹Ý partners with the U.S. Department of Veterans Affairs Geriatric Research, Education and Clinical Center (GRECC) at the Audie L. Murphy Memorial VA Hospital to initiate clinical trials to further advanced knowledge of age-related diseases and provide preventive solutions.
Two National Institute on Aging-funded centers: Nathan Shock and Claude D. Pepper
NIA-sponsored Interventions Testing Program site
U.S. Department of Veterans Affairs Geriatric Research, Education and Clinical Center (GRECC)
In The News
New NIH-funded program aims to grow pipeline of students in aging research across Texas A new multi-site, eight-week research program aims to engage first-year medical students interested in aging medicine. The Sam and Ann Barshop Institute for Longevity and Aging Studies at 51²è¹Ý of Texas at San Antonio Health Science Center received National Institutes […]
Study finds rapamycin shows greatest longevity effect in 20-year NIH Interventions Testing Program The first comprehensive review of two decades of research from the National Institute on Aging’s Interventions Testing Program highlights 13 interventions that show promise in preclinical studies for significantly extending lifespan and improving healthspan. Aging is the major risk factor for […]
Aging affects all living creatures and is the greatest factor in numerous diseases. The greatest health care burdens are borne by diseases in older patients — a population expected to nearly double by 2050, according to U.S. Census Bureau projections. Over the past 30 years, scientists at 51²è¹Ý of Texas Health Science at San […]